Improvement of Light Chain Proximal Tubulopathy without Crystals in IgGλ-type Monoclonal Gammopathy of Undetermined Significance Using Bortezomib and Dexamethasone

Intern Med. 2024 Mar 1;63(5):693-698. doi: 10.2169/internalmedicine.1835-23. Epub 2023 Jul 12.

Abstract

A 70-year-old woman with acute kidney injury, a high serum Creatinine (Cr) level (3.91 mg/dL), and proteinuria (protein/Cr ratio 1.59 g/gCr) was admitted. Serum IgG λ-type and urinary λ-type M proteins were observed. A bone marrow examination indicated monoclonal gammopathy of undetermined significance (MGUS). A renal biopsy showed distended proximal tubular cells, and immunofluorescence identified tissue positive for proximal tubular cell λ light chains. Electron microscopy identified fibril-like structures in the lysosomes. The patient was diagnosed with light chain proximal tubulopathy without crystals in IgG λ-type MGUS and treated with bortezomib and dexamethasone therapy, which improved her renal function.

Keywords: light chain proximal tubulopathy without crystals; monoclonal gammopathy of renal significance; monoclonal gammopathy of undetermined significance; paraprotein-related kidney disease.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bortezomib / therapeutic use
  • Dexamethasone / therapeutic use
  • Female
  • Humans
  • Immunoglobulin G
  • Kidney Diseases*
  • Monoclonal Gammopathy of Undetermined Significance* / diagnosis
  • Monoclonal Gammopathy of Undetermined Significance* / drug therapy
  • Paraproteinemias* / complications
  • Paraproteinemias* / drug therapy

Substances

  • Bortezomib
  • Dexamethasone
  • Immunoglobulin G